MedTrace Logo

Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism

NCT06440044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-07-15

No results posted yet for this study

Summary

Patients with colorectal cancer (CRC) have a higher risk of both venous thromboembolism (VTE) and major bleeding (MB). Patients with CRC are underrepresented in the major trials examining treatment of cancer-associated VTE with anticoagulant.

Conditions

  • Thrombosis, Venous
  • Colo-rectal Cancer
  • Bleeding

Interventions

OTHER

Data collection

A prospectively maintained database query of all patients with CRC and VTE was initially performed, and then each patient's electronic record was reviewed for inclusion criteria.

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • xiaoyan li · Sixth Affiliated Hospital, Sun Yat-sen University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-06-16
Completion
2024-06-16

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06440044 on ClinicalTrials.gov